PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 136 filers reported holding PLIANT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.31 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393,809 | – | 22,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mass General Brigham, Inc | 288,690 | $3,103,418 | 15.11% |
| TRV GP IV, LLC | 2,132,867 | $22,928,320 | 11.34% |
| Blue Owl Capital Holdings LP | 3,004,199 | $32,295,139 | 8.98% |
| GREAT POINT PARTNERS LLC | 2,636,864 | $28,346,288 | 5.43% |
| First Light Asset Management, LLC | 3,401,213 | $36,563,040 | 3.20% |
| Redmile Group, LLC | 3,209,591 | $34,503,103 | 2.09% |
| Deep Track Capital, LP | 5,972,257 | $64,201,763 | 1.92% |
| Fernwood Investment Management, LLC | 496,286 | $5,335,075 | 1.66% |
| Checkpoint Capital L.P. | 232,200 | $2,496,150 | 1.50% |
| Exome Asset Management LLC | 124,000 | $1,333,000 | 1.16% |